Molecular simulation study on concentration effects of rofecoxib with POPC bilayer
1Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin, 300193, PR China.
Abstract:
The interactions between rofecoxib and POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) bilayer were studied using all-atom molecular dynamics simulation method. Four POPC bilayer systems with different number of rofecoxib molecules were constructed to simulate different drug concentration. The free energy of rofecoxib passing across pure POPC bilayer has two minima (at z ∼1.2nm or 1.6nm). As for the high concentration model, the minimum of the free energy profile slightly shifts to the bilayer center. Moreover, the energy change from bulk water to POPC bilayer increases while the central barrier to cross the hydrophobic core of bilayer slightly decreases, suggesting that increasing drug concentration makes it favorable for rofecoxib to partition into the bilayer and easier to pass across bialyer center. Energy analysis show that the stabilization between the selected rofecoxib and other pre-inserted rofecoxib molecule is mainly due to van der Waals interaction energy. The predicted permeability of rofecoxib in high concentration model slightly weakens as compared with low concentration model.
More Related Videos
07:11Dissipative Microgravimetry to Study the Binding Dynamics of the Phospholipid Binding Protein Annexin A2 to Solid-supported Lipid Bilayers Using a Quartz Resonator
Published on: November 1, 2018
10:10Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
Related Concept Videos
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Pharmacodynamic Models: Linear Concentration–Effect Model
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
Pharmacodynamic Models: Logarithmic Concentration–Effect Model
Pharmacodynamic Models: Emax Drug–Concentration Effect Model
In Vitro Drug Dissolution: Compendial Testing Models II
